Dow Jones Newswires: AstraZeneca agrees to buy U.S.-based CinCor in deal valued at $1.3 billion

The Anglo-Swedish pharma giant said that it will initiate a tender offer to acquire all of U.S.-listed clinical-stage biopharmaceutical company CinCor’s CINC outstanding shares.

Previous post : Swiss National Bank estimates it’ll record $143 billion loss
Next post Dow Jones Newswires: Vodafone to sell Vodafone Hungary for $1.81 billion